To determine the status, practices and perception of self-medication among general population of Quetta city, Pakistan. METHODS: Convenience sample was taken from respondents that were patrons of community pharmacies. A questionnaire about status, knowledge and perception against self medication was constructed, content validated and used for data collection. Pharmacists were hired for data collection and analyses were done by SPSS 15. RESULTS: A total of 840 patrons were approached and 784 responded (93.33%). 621 (79.20%) were males and 163 (20.79%) were females. Most respondents (74.25%) admitted to practice of self medication. Males were found to self medicate more (84.36%) than females (15.63%). Practices of self medication were found more in age group of 35-44 (32.27%). Body weakness/sexual problems (21.80%) were the major conditions for which self medication was performed. Multivitamins/sexual performance enhancer (22.36%), NSAIDS (17.65%) and antibiotics (15.32%) were commonly used drugs. Information related to the medicines was taken from people with past exposure (25.90%), chemist/pharmacist (20.50%) and family member (18.75%). Most patients (18.55%) described high physician expenses as the cause of their self medication. A total of 15.67% of the respondents revealed that they trust chemists and pharmacists more due to their past experiences. A total of 66.65% of population perceived that self medication helps them save money while 61.25% believed that self medication is harmless. CONCLUSIONS: Educational campaigns to educate the population about the rational use of medications are needed. The healthcare professionals must pay special attention on this issue. In addition, sale of medicines without prescriptions should be strictly prohibited and monitored by regulatory authorities. 
PIH32 THE ASSOCIATION OF MENOPAUSAL SYMPTOMS, INCLUDING HOT FLASHES, WITH QUALITY OF LIFE, WORK PRODUCTIVITY AND RESOURCE USE

OBJECTIVES:
The current study characterizes health-related quality of life (HRQoL), work productivity, and resource use among women experiencing menopausal symptoms, including hot flashes. METHODS: The study is based on data from the 2005 US National Health and Wellness Survey (N ϭ 41,184), which is a cross-sectional, internet-based survey representative of the adult US population. Women who were aged 40-64, did not report a history of cancer, and provided information regarding the presence of menopausal symptoms were included for analyses (Nϭ8578). Women who reported currently experiencing menopausal symptoms, including hot flashes (nϭ3767), were compared with women who did not report currently experiencing menopausal symptoms (n ϭ 4499), controlling for demographic and health characteristics. Outcomes measures included HRQoL (SF-8), work productivity (WPAI) within the past 7-days, and healthcare resource use within the past 6-months. Normally distributed variables were assessed with multiple regressions, while non-normally distributed variables were assessed with generalized linear models. RESULTS: There was little difference in the mean age of women experiencing hot flashes (50.5 yrs, SDϭ5.2), and women not reporting menopausal symptoms (49.1 yrs, SDϭ6.5). After controlling for demographic and health characteristics, women experiencing hot flashes reported significantly lower mental (46.8 vs. 48.5, pϽ.0001) and physical (45.8 vs. 47.3, pϽ.0001) functioning on the SF-8 component summary scores than women not experiencing menopausal symptoms. In addition, mean percent impairment while at work (25.00% vs. 14.32%, pϽ.001), and in activities of daily living (37.32% vs. 23.16%, pϽ.0001) were higher among women experiencing hot flashes. Furthermore, the annual mean number of ER visits were higher among those with menopause (2.1 vs. 1.9, pϭ.0428).
CONCLUSIONS:
The presence of menopausal symptoms, including hot flashes, was independently and significantly associated with lower levels of mental and physical HRQoL, lower productivity, greater impairment in activities of daily living, and greater resource utilization. , beneficiaries who were 21 to 64 years of age during the 12-month period and were continuously enrolled for 10 months or more were identified. A final set of 89,110 (pre-cap cohort) and 87,518 (post-cap cohort) beneficiaries remained after applying the study inclusion and exclusion criteria. Using segmented regression analysis, trends in medical services utilization and cost per beneficiary per month (PBPM) were examined over the two-year period. RESULTS: In the 12-month period before the implementation of the cap, a decreasing trend in ER visits was observed (coefficientϭ-0.0024, pϽ0.0001). The implementation of the cap resulted in an initial increase in the utilization of ER visits (coefficientϭ0.0160, pϽ0.0001; absolute differenceϭ0.0167 visits PBPM). When examining the ER visit costs, a decreasing month-to-month trend was observed in the 12-month pre-cap period (coefficientϭ-2.4651, pϽ0.001). The implementation of the cap resulted in a decrease in ER visit costs (coefficientϭ-20.554, pϽ0.0001). However, an increasing month-tomonth trend in ER visit costs was observed in the 12-month post-cap period (coefficientϭ1.332, pϭ0.0008). Results for hospitalization and office visit utilization and costs revealed no significant findings. CONCLUSIONS: There was an increase in ER visits utilization among MS Medicaid beneficiaries after the prescription cap implementation. 
PIH35 PHARMACISTS' ATTITUDE AND PREPAREDNESS REGARDING THE ISSUE OF ESCALATING PHARMACEUTICAL DEMAND DUE TO THE AGING BABY BOOMERS
OBJECTIVES:
To assess and evaluate the association between pharmacists' attitude, perceived preparedness, and willingness to prepare regarding the issue of escalating pharmaceutical demand due to the aging baby boomers. METHODS: This was a non-experimental, cross-sectional, field study design. The study sample consisted of registered pharmacists', practicing in chain and independent community pharmacy stores in Houston and surrounding areas. A self-administered survey questionnaire based on the proposed model for the study was developed to address the study objectives. Descriptive analysis followed by paired t-tests (dependent sample); wilcoxon signed-rank tests (independent sample) and spearman correlation analysis were performed to assess the study objectives. RESULTS: A total of 117 pharmacists' responded with an overall response rate of 49.8%. Mean age of the respondents was 41.1 (Ϯ11.1) years, with majority being females (51.7%), African Americans (41.0%), having an average experience of 13.6 (SD Ϯ 11.6) years, working in chain pharmacy setting (77.8%), having a PharmD degree (55.7%) and working full time (91.4%). Non-respondents matched the sample on the gender (pϭ0.75) and practice setting (pϭ0.84). Approximately 60% pharmacists' rated their current workload level as high, with 92% believing their workload level to significantly increase given the rise in the aging baby boomer population over the next two decades. However, nearly 56% pharmacists' believed that the potential changes in workload will not affect their job, patient-care and health related outcomes. Also, approximately 83% pharmacists' agreed to be prepared and willing or very willing to take action, whatever it may be, to better prepare themselves for the aging baby boomer population. CONCLUSIONS: Pharmacists' attitude and perceived preparedness were found to be significantly associated with their willingness to prepare for the aging baby boomer population. Further studies are required to assess the effect of various covariates on pharmacist's willingness to prepare for the aging baby boomer population.
PIH36 DRUG PRESCRIBING BEHAVIOR FOR THE TREATMENT OF HEAVY MENSTRUAL BLEEDING
Hawryluk EA, Horowicz-Mehler N, Popli M Quintiles, Hawthorne, NY, USA OBJECTIVES: Heavy menstrual bleeding (HMB) is defined as excessive menstrual bleeding which interferes with a woman's quality of life. Despite availability of surgical and non-surgical treatments, HMB remains a public health issue with a prevalence of 4-10%. The objective was to examine why many women do not receive medication to treat their HMB. METHODS: The number of visits to physician offices for HMB (ICD-9 code 626.2) in 2009 was collected using SDI's Physician Drug and Diagnostic Audit (PDDA). Additional visit-level data was collected through PDDA, including: the number of visits resulting in a prescription for HMB, the number of visits where patients requested a prescription and other confounding variables such as 1st or subsequent visit, disease severity and comorbidities. The impact of these factors on the likeliness of a patient receiving a prescription for the treatment of HMB was explored. Surgical treatments were not considered in this analysis. RESULTS: In 2009, there were 2,341,000 patient visits to physicians where the primary focus of the visit was the patient's HMB. Overall, patients received a prescription for the treatment of their HMB in 59% of visits. Among the visits with a prescription, only 18% of prescriptions were requested by the patient. Yet, those who requested a prescription were more likely to receive one (73% vs. 57%). Differences existed between prescription and non-prescription groups. GPs were more likely to prescribe for HMB than OB/GYNs (77% vs. 58%). Patients were more likely to request drugs on their first visit versus subsequent doctor visits (54% vs. 46%). CONCLUSIONS: This preliminary analysis demonstrates that although patient visits for HMB are relatively common, few women are actually requesting treatment for their HMB and not all receive medication for their disease. There is a need for further research to determine the factors that contribute to this discrepancy. 
PIH37 DUAL VETERAN HEALTH ADMINISTRATION AND MEDICARE USE AND AMBULATORY CARE SENSITIVE HOSPITALIZATIONS
